期刊
BIOMEDICINES
卷 11, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/biomedicines11102814
关键词
systemic lupus erythematosus; biomarkers; atherosclerosis; interferon signaling; cardiovascular risk; immune cells
Systemic lupus erythematosus is associated with an increased risk of premature atherosclerosis. This review focuses on biomarkers of atherosclerosis in SLE, particularly immune markers. Chronic inflammation of the vascular wall is a significant cause of cardiovascular disease events.
Systemic lupus erythematosus is a chronic connective tissue disease associated with an increased risk of premature atherosclerosis. It is estimated that approximately 10% of SLE patients develop significant atherosclerosis each year, which is responsible for premature cardiovascular disease that is largely asymptomatic. This review summarizes the most recent reports from the past few years on biomarkers of atherosclerosis in SLE, mainly focusing on immune markers. Persistent chronic inflammation of the vascular wall is an important cause of cardiovascular disease (CVD) events related to endothelial dysfunction, cell proliferation, impaired production and function of nitric oxide and microangiopathic changes. Studies on pathogenic immune mediators involved in atherosclerosis will be crucial research avenues for preventing CVD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据